3-(2,5-Dichloropyrimidin-4-yl)-1H-indole is used in the preparation 2-(2,4,5-substituted -anilino)pyrimidine derivatives as EGFR modulators useful for the prevention or treatment of a number of different cancers, in particular non-small cell lung cancer.
